Clinical TrialID 375
Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion
NCT02674243
Malignant Pleural Effusion
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 375
- Evidence Id
- 375
- Core Evidence Id
- 375
- Source Clinical Trial Id
- 362
- Herb2 Clinical Trial Id
- HBCT000362
- Nct Id
- NCT02674243
- Title
- Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion
- Status
- Completed
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Malignant Pleural Effusion
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Iodopovidone solution|DRUG: Talc
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Single
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 60
- Outcome Measure
- Success of treatment, Success of treatment defined as chest drain can be removed within 1 week after intervention, 7 days
- Sponsor Collaborator
- Chiang Mai University
- Funded By
- OTHER
- Location
- Department of surgery, Faculty of medicine, Chiang Mai University Hospital, Chiang Mai, Chaing Mai, 50200, Thailand
- Other Id
- 3315
- Start Date
- 2015-11
- Primary Completion Date
- 2019-12
- Completion Date
- 2019-12
- First Posted
- 2016-02-04
- Results First Posted
- Last Update Posted
- 2020-01-23
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT02674243
- Title Cn
- Title En
- Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion
- Bilingual Status
- semi_complete